Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
Author(s) -
Huldrych F. Günthard,
Michael S. Saag,
Constance A. Benson,
Carlos del Rı́o,
Joseph J. Eron,
Joel E. Gallant,
Jennifer Hoy,
Michael J. Mugavero,
Paul E. Sax,
Melanie Thompson,
Rajesh T. Gandhi,
Raphael J. Landovitz,
Davey M. Smith,
Donna M. Jacobsen,
Paul A. Volberding
Publication year - 2016
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2016.8900
Subject(s) - medicine , tolerability , efavirenz , intensive care medicine , integrase inhibitor , medline , reverse transcriptase inhibitor , antiretroviral therapy , human immunodeficiency virus (hiv) , viral load , family medicine , adverse effect , political science , law
New data and therapeutic options warrant updated recommendations for the use of antiretroviral drugs (ARVs) to treat or to prevent HIV infection in adults.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom